Magna Pharmaceuticals, Inc. Report issue

For profit Phase 3
Founded: Louisville KY United States (1990)
Status: No NME R&D (1990)

Organization Overview

First Clinical Trial
2009
NCT00932256
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rhinitis (Phase 3)

Rhinitis, Allergic (Phase 3)

Rhinitis, Allergic, Seasonal (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 3